Long-Term Clinical and Safety Outcomes of Canaloplasty Performed across All Grades of Glaucoma Severity

CONCLUSION: iTrack canaloplasty achieved a statistically significant IOP reduction in mild-moderate and severe eyes and was found to be an effective option for reducing IOP and medications in patients with mild-moderate primary open-angle glaucoma (POAG). In severe eyes, it has reduced IOP while the medications remained stable.PMID:37207241 | PMC:PMC10191748 | DOI:10.1155/2023/5625990
Source: Journal of Ophthalmology - Category: Opthalmology Authors: Source Type: research